Fate alert: bragar eagel & squire, p.c. is investigating fate therapeutics, inc. on behalf of fate stockholders and encourages investors to contact the firm

New york--( business wire )--bragar eagel & squire, p.c., a nationally recognized stockholder rights law firm, is investigating potential claims against fate therapeutics, inc. (“fate” or the “company”) (nasdaq: fate) on behalf of fate stockholders. our investigation concerns whether fate has violated the federal securities laws and/or engaged in other unlawful business practices.
FATE Ratings Summary
FATE Quant Ranking